|
RYK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.688400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.974200E-01 |
| Normal-vs-Stage2 |
6.772200E-01 |
| Normal-vs-Stage3 |
9.150600E-01 |
| Normal-vs-Stage4 |
1.617150E-01 |
| Stage1-vs-Stage2 |
5.559600E-01 |
| Stage1-vs-Stage3 |
7.721000E-01 |
| Stage1-vs-Stage4 |
3.254200E-01 |
| Stage2-vs-Stage3 |
8.050600E-01 |
| Stage2-vs-Stage4 |
2.289400E-01 |
| Stage3-vs-Stage4 |
3.446000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.686600E-01 |
| Normal-vs-AfricanAmerican |
8.411600E-01 |
| Normal-vs-Asian |
4.212600E-01 |
| Caucasian-vs-AfricanAmerican |
6.885800E-01 |
| Caucasian-vs-Asian |
5.176400E-01 |
| AfricanAmerican-vs-Asian |
5.372800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.732000E-01 |
| Normal-vs-Female |
2.601700E-02 |
| Male-vs-Female |
8.917500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.598800E-01 |
| Normal-vs-Extreme_Weight |
6.840000E-01 |
| Normal-vs-Obese |
5.108800E-01 |
| Normal-vs-Extreme_Obese |
7.623800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.232400E-01 |
| Normal_Weight-vs-Obese |
2.754600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.792400E-01 |
| Extreme_Weight-vs-Obese |
3.140600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.812800E-01 |
| Obese-vs-Extreme_Obese |
5.197400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.810300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.619410E-01 |
| Normal-vs-Age(61-80Yrs) |
7.922000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.771190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.203180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.787800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.658400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.149370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.031200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.965700E-02 |
| Normal-VS-Type2 PRCC |
2.360200E-03 |
| Normal-VS-KIRP CIMP |
1.114600E-01 |
| Normal-VS-Unclassified PRCC |
3.037400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.35939995003088E-09 |
| Type1 PRCC-VS-KIRP CIMP |
2.775400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.324800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.199300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.919700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.643800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.566200E-02 |
| Normal-vs-N1 |
5.456600E-01 |
| Normal-vs-N2 |
8.240000E-01 |
| N0-vs-N1 |
8.570200E-02 |
| N0-vs-N2 |
6.883600E-01 |
| N1-vs-N2 |
6.359800E-01 |
|
|
